Alloy
Waltham, US · Founded 2017 · 152 employees on LinkedIn · 4 known investors
Find your way into Alloy
Alloy provides drug discovery services and platform technologies across genetic medicines, TCR mimics, and cell therapies, supporting pharmaceutical partners in developing novel treatments.
Founders & leadership
Alloy was founded in 2017 by Tillman Gerngross.
TG
Tillman GerngrossFounder, CEO, Chairman
Investors · 4
Competitors · 3
by search overlap
Eli Lilly52 shared keywordsEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.
IQVIA49 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Bioworld47 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Alloy for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Alloy do?
- Alloy provides drug discovery services and platform technologies across genetic medicines, TCR mimics, and cell therapies, supporting pharmaceutical partners in developing novel treatments.
- Who founded Alloy?
- Alloy was founded by Tillman Gerngross in 2017.
- Who are Alloy's investors?
- Alloy's investors include 82VS, 8VC, Calm Ventures, Germin8 Ventures.
- Where is Alloy headquartered?
- Alloy is headquartered in Waltham, US.